CNMD Form 144: Planned sale of 257 CONMED common shares

Rhea-AI Filing Summary

CONMED Corporation (CNMD) reported a planned sale of company stock by an affiliate under Rule 144. The notice covers the proposed sale of 257 shares of CNMD common stock through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of $10,590.97. The filing states that the issuer had 30,967,954 shares outstanding of the same class at the time referenced.

The 257 shares being sold were acquired on 11/20/2025 through a restricted stock vesting transaction from the issuer, with the consideration classified as compensation. The person for whose account the securities are to be sold must represent that they are not aware of any undisclosed material adverse information about CONMED’s current or prospective operations before proceeding with the sale.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	257	10590.97	30967954	11/21/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/20/2025	Restricted Stock Vesting	Issuer			257	11/20/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does CONMED (CNMD) disclose in this Form 144 filing?

The Form 144 discloses a planned sale of 257 shares of CONMED common stock, with an aggregate market value of $10,590.97, to be sold on the NYSE through Fidelity Brokerage Services LLC under Rule 144.

How many CONMED (CNMD) shares are planned to be sold and on which exchange?

The notice covers the planned sale of 257 shares of CONMED common stock, to be sold on the NYSE through Fidelity Brokerage Services LLC.

What is the reported market value of the CONMED (CNMD) shares in this Form 144?

The aggregate market value of the 257 shares of CONMED common stock covered by the notice is listed as $10,590.97.

How and when were the CONMED (CNMD) shares being sold acquired?

The 257 shares to be sold were acquired on 11/20/2025 via a restricted stock vesting transaction from the issuer, with the nature of payment described as compensation.

How many CONMED (CNMD) common shares were outstanding according to this notice?

The notice states that there were 30,967,954 shares of CONMED common stock outstanding for the class of securities referenced.

What representation must the selling person make in this CONMED (CNMD) Form 144?

The selling person must represent by signing that they do not know any material adverse information about CONMED’s current or prospective operations that has not been publicly disclosed.